The court last month ordered an “interim status quo” on the deal, pending a decision on a petition for a probe into alleged insider trading.
High Court Lifts Stay on Sun Pharma’s $3.2 Billion Ranbaxy Takeover
More from NewsMore posts in News »
- €500 million in private sector investments headed for Ukraine
- RBI asks banks to share information on exposure to Adani Group companies – Business Standard
- NSE puts some Adani firms under watch: What is additional surveillance mechanism (ASM)? – The Indian Express
- Hindenburg bet against India’s Adani puzzles rival U.S. short sellers – Reuters India
- Gautam Adani fails to calm investors as market wipeout hits $100 billion – CNN